Project title
採用開放標記、劑量遞增方式，評估HibmLT疫苗在健康受試者之第一期臨床安全性試驗(I)
Internal ID
NSC102-2325-B002-076
Principal Investigator
Start Date
May 1, 2013
End Date
April 12, 2014
Partner Organizations
Project Web Site
An Open-Label, Dose-Escalating Phase 1 Safety Study of HibmLT Vaccine in Healthy Volunteers (I)
Keywords
b 型嗜血桿菌疫苗
新接合蛋白
多醣
臨床一期試驗
HibmLT Vaccine
LTh(αK)
PRP (Polyribosyl-ribitol phosphate)
Phase 1
clinical trial
clinical trial